Sintilimab in Combination with Stereotactic Body Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Metastatic Non-Small Cell Lung Cancer: The Multicenter SWORD Phase 2 Trial

Authors: Zhu Zhengfei et al. Fudan University Shanghai Cancer Center Translated by: Kong Yuehong Reviewed by: Zhang Liyuan PRaG Treatment Center, The Second Affiliated Hospital of Soochow University Advanced driver gene-negative non-small cell lung cancer (NSCLC) refers to lung cancer patients without common oncogenic driver mutations (such as EGFR, ALK, etc.). These patients typically do…

Latest Research from the Department of Head and Neck Radiotherapy at Zhejiang Cancer Hospital: Chen Xiaozhong and Cao Canneng Team | New Voice in Radioimmunotherapy for Glioblastoma

Source of Research Article: Cao C, Wang L, Jiang F, et al. Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma. Neoplasia. 2025; 47:101156. Recently, the research team led by Professor Chen Xiaozhong and Professor Cao Canneng from Zhejiang Cancer Hospital published their latest research findings on radiotherapy and chemotherapy combined with GM-CSF. Their treatment regimen for…